Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.37 - $0.99 $542,420 - $1.45 Million
-1,466,000 Reduced 22.73%
4,984,871 $1.89 Million
Q4 2022

Feb 14, 2023

SELL
$1.82 - $2.71 $1.14 Million - $1.7 Million
-627,148 Reduced 8.86%
6,450,871 $13 Million
Q3 2022

Nov 14, 2022

BUY
$2.5 - $4.73 $1.85 Million - $3.51 Million
741,689 Added 11.71%
7,078,019 $17.7 Million
Q2 2022

Aug 15, 2022

SELL
$2.86 - $6.44 $788,470 - $1.78 Million
-275,689 Reduced 4.17%
6,336,330 $24.2 Million
Q1 2022

May 16, 2022

SELL
$5.94 - $12.09 $14.9 Million - $30.2 Million
-2,500,000 Reduced 27.44%
6,612,019 $41.7 Million
Q2 2021

Aug 16, 2021

BUY
$23.16 - $31.17 $211 Million - $284 Million
9,112,019 New
9,112,019 $250 Million

Others Institutions Holding OMIC

About Singular Genomics Systems, Inc.


  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.1B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.